Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (164723)	5/19/2020 3:26:00 PM
From: bentway	Read Replies (2) \| Respond to of 361771

There IS a VERY large group that's been taking HCQ to treat their lupus and auto-immune disorders, long before the virus became a problem. Are they safe from covid-19? NO: Are People with Lupus Protected Against COVID-19? There is no evidence that taking hydroxychloroquine (Plaquenil) is effective in preventing a person from contracting the coronavirus (COVID-19). People with lupus should follow the guidance of their doctor and the safety guidelines being issued by the CDC. lupus.org

To: Lane3 who wrote (164723)	5/19/2020 4:37:54 PM
From: i-node	Read Replies (1) \| Respond to of 361771

>> Do you also get that there's no way to prove HCQ's efficacy at clinical trial without infecting the subjects I don't even comprehend your point. It is not different from clinical trials for cancer. A sick person comes in, they agree to participate in the clinical trial, and they are randomized into one of multiple treatment options. Which may [or may not] include placebo. If it is determined a treatment option is so efficacious that it is unethical not to offer a given treatment to the entire study, the study will be stopped and the offer will be extended. This is done all the time.